Map Allergies

Featured Article

MAP's drug, Levadex, showed statistical significance at two hours compared to placebo at relieving common symptoms of migraine: pain, nausea, and sensitivity to light and sound.

Levadex, formerly called MAP0004, also reached secondary measures of the 792-patient trial, including pain relief at 30 minutes and sustained relief for 48 hours.

Read more

More information on "Map Allergies"

From Our Experts

See more SharePosts »

From Our Sources

More on Allergy »